ACCP collaborates with ASHP on Ambulatory Care Pharmacy activities.

• Target Audience
• Series Overview
• Program Content
• Faculty, Reviewers, and Disclosures
• Learning Objectives
• Continuing Pharmacy Education Credit
• BCOP Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

These recertification activities are intended for Board Certified Ambulatory Care Pharmacists (BCACPs) and those interested in impacts of ageism, non-dialysis chronic kidney disease, stroke risk with directoral anticoagulants, and opioid use disorder. 

2021 ACCP/ASHP BCACP Clinical Sessions have been approved by the Board of Pharmacy Specialties for recertification of Board-Certified Ambulatory Care Pharmacists (BCACPs). The sessions are jointly sponsored by ACCP and the American Society of Health-System Pharmacists.

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Release date: December 15, 2021
BCACP credit expiration date: December 15, 2022
ACPE credit expiration date: December 13, 2024

The 2021 BCACP Clinical Sessions are offered in four presentations. Each presentation focuses on a different Ambulatory Care topic that is highly relevant for day-to-day practice. Topics include impacts of ageism, non-dialysis chronic kidney disease, stroke risk with direct oral anticoagulants, and opioid use disorder.

Impact of Ageism on Therapeutic Outcomes and Patient-Provider Relationships

	Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS, FASCP Professor & Division Head – Geriatrics Texas Tech University HSC School of Pharmacy Dallas, Texas

Infiltrating the Kidneys: Non-Dialysis CKD in Primary Care

	Maria C. Pruchnicki, Pharm.D., FCCP, BCPS, BCACP, CLS Associate Professor – Clinical The Ohio State University College of Pharmacy; Specialty Pharmacist – Ambulatory The Ohio State University Wexler Medical Center Columbus, Ohio
	Tiffany Shin, Pharm.D. Clinical Assistant Professor University of Kansas School of Pharmacy Wichita, Kansas

Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease

	Zachary R. Noel, Pharm.D., BCPS, BCCP Assistant Professor University of Maryland School of Pharmacy Baltimore, Maryland
	Barbara J. Zarowitz, Pharm.D., FCCP, GASCP, BCPS, BCGP, LMSW, CADC-i Affiliate Professor University of Maryland School of Pharmacy; Senior Advisor Peter Lamy Center on Drug Therapy and Aging Baltimore, Maryland

Road to Recovery: Caring for Persons Living with Opioid Use Disorder in an Ambulatory Care Setting

	Cherry W. Jackson, Pharm.D., FCCP, FASHP, BCPP Professor of Pharmacy Practice Auburn University Clinical Professor of Psychiatry and Behavioral Neurobiology University of Alabama Birmingham, Alabama
	Krystal Riccio, Pharm.D., BCACP, CDCES Associate Professor of Pharmacy Practice Roseman University of Health Sciences College of Pharmacy; Clinical Pharmacist Center for Behavioral Health Las Vegas, Nevada

• Holly L. Byrnes, Pharm D., BCPS
• Dana Carroll, Pharm.D., BCPS, CDE, BCGP
• Susan R. Dombrowski, M.S., R.Ph.
• Irene Hanna, Pharm.D., BCACP, CDCES
• Michelle Hilaire Pharm.D., BCACP, BCPS, CDE, FCCP
• Kristi Hofer, Pharm.D.
• Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
• Maria Shin, Pharm.D., BCGP, BCPS
• Kenyu Tan, Pharm.D., BCACP, BCPS, BCGP

Faculty and Reviewer Disclosures 

Learning Objectives 

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

BCACP and BCGP Clinical Session
Impact of Ageism on Therapeutic Outcomes and Patient-Provider Relationships
Activity Number: 0204-9999-21-237-H04-P
Contact Hours: 1.00
Activity Type: Application-Based Activity

BCACP and BCGP Clinical Session
Infiltrating the Kidneys: Non-Dialysis CKD in Primary Care
Activity Number: 0217-9999-21-155-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

BCACP and BCGP Clinical Session
Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease
Activity Number: 0204-9999-21-321-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

BCACP Clinical Session
Road to Recovery: Caring for persons living with opioid use disorder in an ambulatory care setting
Activity Number: 0217-9999-21-154-H08-P
Contact Hours: 2.00
Activity Type: Application-Based Activity

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by December 13, 2024. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

To be eligible to earn BCACP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by December 15, 2022. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

The passing point to earn BCACP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCACP posttest deadline that meets this passing point will earn BCACP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCACP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.

• Internet browser
• Adobe Reader (available free)

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.